Complete response (CR) observed in 70% (35/50) of patients with low-grade upper tract urothelial cancer (UTUC) who completed ...

Scientists have found that common foods can contain hidden contaminants formed during cooking or through environmental ...

Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for ...

Teva Pharmaceutical Industries has announced the findings from the final analysis of the real-world pan-European PEARL Phase ...

Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12 weeks observed after a ...

In a remarkable stride towards environmental sustainability, researchers at the Department of Biotechnology and Medical ...

Zurich, Switzerland, December 03, 2025 - MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive ...

Argenica Therapeutics shares have surged higher after positive clinical trial results for its stroke treatment drug.

Evercore 8th Annual Healthcare Conference December 3, 2025 2:35 PM ESTCompany ParticipantsSteven Harr - President, CEO ...

Although this is one route for a diagnostic device, securing FDA approval allows Cleveland Diagnostics to send IsoPSA kits ...

For both health systems and investors, the most exciting signal is how AI amplifies advances in biotechnology.

A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers lessons learned to inform best practices as manufacturers and medical centers ...